Related Experiment Video
Updated: Mar 29, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Emergency Room Treatment of Hypertensive Crises
Sabina Salkic1, Selmira Brkic2, Olivera Batic-Mujanovic3
1Emergency Medical Service Department, Community Health Care Center Tuzla.
Insights
Urapidil demonstrates superior efficiency in treating hypertensive urgency compared to captopril. While urapidil showed significant blood pressure reduction, captopril was more effective in older hypertensive patients.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Hypertensive urgency requires prompt and effective treatment to prevent target organ damage.
- Alpha-1 adrenergic receptor inhibitors and angiotensin-converting enzyme (ACE) inhibitors are commonly used in managing hypertensive emergencies.
- Evaluating treatment efficacy based on patient demographics and hypertension history is crucial for optimizing care.
Purpose of the Study:
- To assess the effectiveness of urapidil (an alpha-1 adrenergic receptor inhibitor) versus captopril (an ACE inhibitor) in treating hypertensive urgency.
- To analyze treatment efficiency in relation to patient age, duration of hypertension, and severity.
Main Methods:
- A study involving 120 patients (aged 40-80) with verified hypertensive urgency was conducted.
- Patients were divided into two groups: a control group receiving sublingual captopril and an experimental group receiving intravenous urapidil.
- Blood pressure was monitored after initial and subsequent doses of the assigned medications.
Main Results:
- The study included patients aged 40-80, with the highest prevalence in the 60-69 age group. Average hypertension duration was 11-20 years.
- Initial average blood pressure was 213/130 mmHg. After treatment, both groups showed decreased blood pressure, with urapidil group showing a statistically significant reduction in mean artery pressure (p<0.001).
- No significant difference in urapidil's efficiency was noted with patient age, but captopril was more effective in older patients (p=0.02). Treatment efficiency did not significantly differ based on hypertension duration for either drug.
Conclusions:
- Urapidil is a more efficient treatment for hypertensive urgency due to a statistically significant reduction in mean artery pressure.
- While urapidil's efficacy is independent of age, captopril demonstrated greater effectiveness in older individuals.
- Neither urapidil nor captopril showed a statistically significant difference in efficiency concerning the duration of hypertension.
Aim:
The aim of the study was to evaluate efficiency of hypertensive urgency treatment using inhibitors of α1-adrenergic receptors and angiotensin converting enzyme inhibitors-ACE inhibitors in the Emergency Room of Outpatient Hospital and Polyclinic "dr Mustafa Šehovic" Tuzla in relation to age, duration and severity of hypertension.
Methods:
The study was conducted from June 2011 to May 2012 and included 120 patients of both sexes diagnosed with arterial hypertension, aged 40 to 80 with verified hypertensive urgency. The patients were divided into two groups: the control group treated with sublingual captopril and the experimental group treated intravenously with urapidil.
Results:
The results show that the largest number of patients belonged to age group from 60 to 69 years (34,16%), and the average age was 58 (11). The largest number of patients (38,0%) had verified hypertension for 11 to 20 years. The average systolic/diastolic artery blood pressure at reception was 213 (19) / 130 (4) mmHg. The average systolic/diastolic artery blood pressure after the first dose of 12,5 mg captopril in the control group was 177,42 (10,91) / 112,33 (3,50) mmHg, while after the first dose of 12,5 mg urapidil it was 179,25 (16,62) / 110,33 (8,78) mmHg. The average systolic/diastolic artery blood pressure after the second dose of 12,5 mg of captopril in the control group was 152,00 (6,32) / 95,50 (3,76) mmHg, while after the second dose of 12,5 mg of urapidil it was 152,55 (7,17) / 95,29 (5,04) mmHg.
Conclusion:
Urapidil is more efficient in hypertensive urgency treatment, since the decrease of middle artery pressure (MAP) in the group treated with urapidil was statistically significant (p<0,001). No statistical significance was found between the efficiency of urapidil and the patient's age, while captopril was more efficient in older patients (p=0,02). Also, no statistically significant difference was found between the efficiency of captopril and urapidil in relation to duration of hypertension.
More Related Videos
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
Related Concept Videos
Hypertension I: Introduction
Hypertension V: Nursing Management
Heart Failure V: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management